Inventor · disambiguated record
Sarala Balachandran
Also filed as: BALACHANDRAN SARALA
4 granted patents·10 pending applications·7 citations·filing 2004–2012
60Inventor score
Top patents by PatentIndex Score
14 records- 0169US7825147B2Inhibitors of phosphodiesterase type-IVRANBAXY LAB LTD·Filed 2004·Granted Nov 2, 2010·7 cites·6 claims
- 0255US2014045832A1Insulin-Like Growth Factor-1 Receptor InhibitorsBALACHANDRAN SARALA·Filed 2012·Application pending·0 cites
- 0341US2010029728A1Phosphodiesterase inhibitorsRANBAXY LAB LTD·Filed 2007·Application pending·0 cites
- 0439US7915286B2Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitorsRANBAXY LAB LTD·Filed 2006·Granted Mar 29, 2011·0 cites·5 claims
- 0538US2011130403A1Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitorsRANBAXY LAB LTD·Filed 2008·Application pending·0 cites
- 0636US7781460B2Substituted indazoles as inhibitors of phosphodiesterase type-IVRANBAXY LAB LTD·Filed 2006·Granted Aug 24, 2010·0 cites·3 claims
- 0736US2011021473A1Inhibitors of phosphodiesterase type-ivRANBAXY LAB LTD·Filed 2007·Application pending·0 cites
- 0834US2008280926A1Phosphodiesterase InhibitorsPALLE VENKATA P·Filed 2004·Application pending·0 cites
- 0934US2007259874A1Phosphodiesterase InhibitorsPALLE VENKATA P·Filed 2004·Application pending·0 cites
- 1031US2010022571A1Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitorsPALLE VENKATA P·Filed 2006·Application pending·0 cites
- 1131US2009221566A1Inhibitors of phosphodiesterase type-ivPALLE VENKATA P·Filed 2006·Application pending·0 cites
- 1230US8420666B2Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitorsRUDRA SONALI·Filed 2008·Granted Apr 16, 2013·0 cites·14 claims
- 1327US2009048247A1Condensed isoxaline derivatives as inhibitors of phosphodiesterase type - ivPALLE VENKATA P·Filed 2006·Application pending·0 cites
- 1427US2008009535A1Inhibitors of phosphodiesterase type-IVBALACHANDRAN SARALA·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →